Login / Signup

Outcomes and Patency of Endovascular Infrapopliteal Reinterventions in Patients With Chronic Limb-Threatening Ischemia.

Simone F KleissPatricia A H van Mierlo-van den BroekCornelis G VosBram FiooleGijs C BloemsmaDebbie A B de Vries-WersonReinoud P H BokkersJean-Paul P M de Vries
Published in: Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists (2023)
This multicenter retrospective study evaluating outcome and patency of endovascular infrapopliteal reinterventions for CLTI, shows that endovascular infrapopliteal reinterventions can be performed with acceptable 30-day mortality and complication rates. However, the short- and mid-term outcomes of the infrapopliteal reinterventions were moderate to poor, with low rates of AFS and a high need for recurrent reinterventions. While the frequency of performing infrapopliteal reinterventions is increasing with additional growing complexity of the disease, alternative treatment options such as venous bypass grafting or deep venous arterialization may be considered and should be studied in randomized controlled trials.
Keyphrases
  • randomized controlled trial
  • cardiovascular disease
  • aortic dissection
  • cardiovascular events
  • cross sectional
  • metabolic syndrome
  • adipose tissue
  • risk factors
  • glycemic control
  • double blind